EMEA-002135-PIP01-17

Key facts

Active substance
  • Ezetimibe
  • rosuvastatin calcium
Therapeutic area
Cardiovascular diseases
Decision number
P/0185/2017
PIP number
EMEA-002135-PIP01-17
Pharmaceutical form(s)
Tablet
Condition(s) / indication(s)
Treatment of elevated cholesterol
Route(s) of administration
Oral use
Contact for public enquiries
BENEDETTI & Co. S.r.l.
Italy
Tel. +39 0573474007
Fax +39 0573474963
Email: g.delorenzo@bencospa.it
Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating